13 results
·
29ms
·
Sources: EU EUDAMED, US FDA
MEVION S250i
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·January 16, 2019
MEVION S250/MEVION S250i Proton Beam Radiation therapy system Product Usage: Indicated for the delivery of radiation for the treatment of patients with localized tumors or other conditions susceptible to treatment by radiation.
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·August 22, 2018
MEVION S250 Product Usage: Proton Radiation Therapy
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·November 23, 2016
MEVION S250, used for proton radiation therapy.
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·December 17, 2014
MEVION S250 Product Usage: Proton Radiation Therapy System
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·November 23, 2016
MEVION S250, System, Radiation Therapy, Charged-Particle, Medical used for Proton Radiation Therapy Product Usage: Proton Radiation Therapy
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·April 2, 2014
MEVION S250-Proton Radiation Therapy Product Usage: Proton Radiation Therapy
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·February 8, 2017
MEVION S250 Radiation therapy system
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·February 17, 2016
MEVION S250 Product Usage: Proton Radiation Therapy System
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·November 23, 2016
MEVION S250 for Proton Radiation Therapy
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·April 27, 2016
MEVION S250 Proton Radiation Treatment System; intended to deliver proton radiation treatment to patients
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·July 29, 2020
MEVION S250i, MEVION S250; Proton Radiation Treatment System
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·July 1, 2020
MEVION S250i, MEVION S250; Proton Radiation Treatment System - Product Usage: intended to deliver proton radiation treatment to patients with localized tumors or any other conditions susceptible to treatment by radiation
FDA Enforcement
Class II
·Terminated·Mevion Medical Systems, Inc.·December 2, 2020